期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Assessment of C-Reactive Protein/Serum Albumin Ratio in Relation to Acute Presentation and Early Outcome of Patients with Acute Coronary Syndrome
1
作者 Waseem F. Al Tameemi Noor Alaa Alkhazraji 《Journal of Biosciences and Medicines》 CAS 2023年第2期239-253,共15页
Background: Acute coronary syndrome (ACS) is the leading cardiovascular (CV) cause of mortality. C reactive protein (CRP) has linked with long-term risk of recurrent cardiovascular events or death. Albumin, in contras... Background: Acute coronary syndrome (ACS) is the leading cardiovascular (CV) cause of mortality. C reactive protein (CRP) has linked with long-term risk of recurrent cardiovascular events or death. Albumin, in contrast to CRP known as a negative acute-phase protein. Thus a newly introduced marker assessed relation of CRP to albumin ratio (CAR), which may provide better results than the use of either marker alone. The aim of the study is to assess the association of C-reactive protein to albumin ratio (CAR) with in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients. Patients & Methods: A multi-centers prospective cohort study was conducted at coronary intensive care units (CICU) in Baghdad during the period from March to October 2021 that included a total of 132 patients who were diagnosed as a case of ACS. They were assessed for major adverse cardiac events (MACEs) like cardiogenic shock, arrhythmias, post-MI angina, and acute heart failure while inside the ward, in addition to need for early interventional therapeutic approach in relation to (CAR) immediately at time of admission to hospital. Results: High values of CAR, whether using hs-CRP or CRP, were identified as an independent predictor for in-hospital MACEs (P value Conclusion: The CAR was independently correlated with in-hospital short-term MACEs and can be used for risk stratification in patients with ACS. 展开更多
关键词 Acute Coronary Syndrome Cardiac Events C Reactive Protein ALBUMIN
下载PDF
血管外科手术病人中的血小板基因多态性和心脏风险评估 被引量:1
2
作者 Nauder Faraday Elizabeth A.Martinez +9 位作者 Robert B.Scharpf Laura Kasch-Semenza Todd Dorman Peter J.Pronovost Bruce Perler Gary Gerstenblith Paul F.Bray Lee A.Fleisher 李敬远(译) 曾因明(审) 《国外医学(麻醉学与复苏分册)》 2005年第1期58-61,共4页
关键词 血管外科手术 血小板 基因多态性 心脏疾病 围术期 心肌缺血
下载PDF
颅内出血患者抗栓药逆转指南美国神经重症监护学会和美国重症医学会对医疗卫生专业人员的声明 被引量:24
3
作者 Jennifer A. Frontera John J. Lewin Ⅲ +15 位作者 Alejandro A. Rabinstein Imo P. Aisiku Anne W. Alexandrov Aaron M. Cook Gregory J. del Zoppo Monisha A. Kumar Ellinor I. B. Peerschke Michael F. Stiefel Jeanne S Teitelbaum Katja E. Wartenberg Cindy L. Zerfoss 杨一萍 谢丽丽 宁小金 季宇腾 柯开富 《国际脑血管病杂志》 2016年第11期961-985,共25页
背景抗栓药的使用,包括抗凝药、抗血小板药和溶栓药,在过去10年中日益增多并且预计将继续上升。虽然抗栓药相关性颅内出血可能是灾难性的,但快速逆转凝血功能障碍可能有助于限制血肿增大和改善转归。方法美国神经重症监护学会联合美... 背景抗栓药的使用,包括抗凝药、抗血小板药和溶栓药,在过去10年中日益增多并且预计将继续上升。虽然抗栓药相关性颅内出血可能是灾难性的,但快速逆转凝血功能障碍可能有助于限制血肿增大和改善转归。方法美国神经重症监护学会联合美国重症医学会组建了一个国际性多机构委员会,涉及的专业领域包括神经重症监护、神经内科、神经外科、卒中、血液学、血液病理学、急诊医学、药学、护理和指南制定,目的是进行文献评价并制定一份循证实践指南。该委员会进行了正式的文献检索,并对符合标准的研究进行了评价。结果利用GRADE方法学,委员会提出了在颅内出血情况下逆转维生素K拮抗药、直接Xa因子拮抗药、直接凝血酶抑制药、普通肝素、低分子肝素、类肝素、戊多糖、溶栓药和抗血小板药的推荐意见。结论该指南提供了及时和循证的抗栓药逆转策略以协助临床医生治疗抗栓药相关性颅内出血。 展开更多
关键词 抗凝药 抗血小板药 抗栓药 颅内出血 脑出血 脑实质出血 蛛网膜下腔出血 硬膜下出血 逆转 解药 维生素K拮抗药 华法林 香豆素 直接凝血酶抑制药 达比加群 Xa因子抑制药 阿哌沙班 利伐沙班 依杜沙班 低分子肝素 肝素 类肝素 戊多糖 磺达肝素 TPA rtPA 阿替普酶 溶栓药 纤溶酶原激活物 阿司匹林 氯吡格雷 凝血酶原复合物 新鲜冰冻血浆 重组因子Ⅶa 鱼精蛋白 血小板 去氨加压素 冷沉淀 指南 GRADE标准
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部